256 related articles for article (PubMed ID: 33092195)
1. Belching in Gastroesophageal Reflux Disease: Literature Review.
Sawada A; Fujiwara Y; Sifrim D
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33092195
[TBL] [Abstract][Full Text] [Related]
2. Diaphragmatic Breathing Reduces Belching and Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms.
Ong AM; Chua LT; Khor CJ; Asokkumar R; S/O Namasivayam V; Wang YT
Clin Gastroenterol Hepatol; 2018 Mar; 16(3):407-416.e2. PubMed ID: 29104130
[TBL] [Abstract][Full Text] [Related]
3. Supragastric belching in Japan: lower prevalence and relevance for management of gastroesophageal reflux disease compared to United Kingdom.
Sawada A; Itami H; Nakagawa K; Hirano S; Kitamura H; Nakata R; Takashima S; Abe Y; Saito M; Yazaki E; Kawamura O; Tanaka F; Takeuchi T; Koike T; Masamune A; Fujiwara Y; Higuchi K; Sifrim D
J Gastroenterol; 2020 Nov; 55(11):1046-1053. PubMed ID: 32839926
[TBL] [Abstract][Full Text] [Related]
4. Identification of Different Phenotypes of Esophageal Reflux Hypersensitivity and Implications for Treatment.
Sawada A; Guzman M; Nikaki K; Sonmez S; Yazaki E; Aziz Q; Woodland P; Rogers B; Gyawali CP; Sifrim D
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):690-698.e2. PubMed ID: 32272249
[TBL] [Abstract][Full Text] [Related]
5. Belching Disorders and Rumination Syndrome: A Literature Review.
Sawada A; Fujiwara Y
Digestion; 2024; 105(1):18-25. PubMed ID: 37844547
[TBL] [Abstract][Full Text] [Related]
6. The influence of supragastric belching severity on esophageal acid exposure and motility.
Sergeev I; Velosa M; Mardare R; Yazaki E; Sifrim D
Neurogastroenterol Motil; 2023 Apr; 35(4):e14520. PubMed ID: 36537295
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of symptomatic belching in patients with belching disorder and patients who exhibit gastroesophageal reflux disease with belching.
Jeong SO; Lee JS; Lee TH; Hong SJ; Cho YK; Park J; Jeon SR; Kim HG; Kim JO
J Neurogastroenterol Motil; 2021 Apr; 27(2):231-239. PubMed ID: 33424014
[TBL] [Abstract][Full Text] [Related]
8. Impact of laparoscopic antireflux surgery on belching in pediatric GERD patients.
Rinsma NF; Mauritz FA; van Heurn LW; Sloots CE; Siersema PD; Houwen RH; van der Zee DC; Masclee AA; Conchillo JM; Van Herwaarden-Lindeboom MY
Neurogastroenterol Motil; 2016 Oct; 28(10):1525-32. PubMed ID: 27151185
[TBL] [Abstract][Full Text] [Related]
9. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors.
Yadlapati R; Tye M; Roman S; Kahrilas PJ; Ritter K; Pandolfino JE
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):211-218.e1. PubMed ID: 28911949
[TBL] [Abstract][Full Text] [Related]
10. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
11. Supragastric Belching: Prevalence and Association With Gastroesophageal Reflux Disease and Esophageal Hypomotility.
Koukias N; Woodland P; Yazaki E; Sifrim D
J Neurogastroenterol Motil; 2015 Jul; 21(3):398-403. PubMed ID: 26130635
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal Reflux Characteristics in Supragastric Belching Patients With Positive Versus Negative pH Monitoring: An Evidence of Secondary Gastroesophageal Reflux Disease From Excessive Belching.
Keeratichananont S; Patcharatrakul T; Gonlachanvit S
J Neurogastroenterol Motil; 2023 Jul; 29(3):343-351. PubMed ID: 37417261
[TBL] [Abstract][Full Text] [Related]
13. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
14. Does severe and chronic esophageal distension by air (observed in SGB and GB) affect the esophageal mucosa integrity (MNBI).
Voulgaris T; Hoshino S; Sifrim D; Yazaki E
Neurogastroenterol Motil; 2024 Mar; 36(3):e14731. PubMed ID: 38148498
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms.
Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K
J Gastroenterol; 2021 Feb; 56(2):117-124. PubMed ID: 33247348
[TBL] [Abstract][Full Text] [Related]
16. Supragastric belching: Pathogenesis, diagnostic issues and treatment.
Popa SL; Surdea-Blaga T; David L; Stanculete MF; Picos A; Dumitrascu DL; Chiarioni G; Ismaiel A; Dumitrascu DI
Saudi J Gastroenterol; 2022; 28(3):168-174. PubMed ID: 35562166
[TBL] [Abstract][Full Text] [Related]
17. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux.
Glasinovic E; Wynter E; Arguero J; Ooi J; Nakagawa K; Yazaki E; Hajek P; Psych CC; Woodland P; Sifrim D
Am J Gastroenterol; 2018 Apr; 113(4):539-547. PubMed ID: 29460918
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
20. [Belching].
Cho YK
Korean J Gastroenterol; 2017 Dec; 70(6):273-277. PubMed ID: 29277088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
